Technology
Health
Pharmaceutical

Sonoma Pharmaceuticals

$6.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.29 (-4.48%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SNOA and other stocks, options, ETFs, and crypto commission-free!

About SNOA

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Read More Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.

Employees
254
Headquarters
Petaluma, California
Founded
1999
Market Cap
8.14M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
12.02K
High Today
$6.39
Low Today
$5.93
Open Price
$6.39
Volume
11.28K
52 Week High
$25.20
52 Week Low
$5.76

Collections

Technology
Health
Pharmaceutical
Healthcare
US
North America

SNOA Earnings

-$2.45
-$1.71
-$0.97
-$0.23
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
-$1.79 per share
Actual
-$2.45 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.